Inmode Ltd (INMD) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Inmode Ltd   (NASDAQ: INMD)


Inmode Ltd 's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Inmode Ltd 's ROA in the fourth quarter of 2025?
Inmode Ltd achieved a return on average assets (ROA) of 12.18 % in its fourth quarter of 2025, which is below Inmode Ltd 's average return on assets, which stands at 23.86%.

ROA fell compared to the third quarter of 2025, despite the net income growth of % from the third quarter of 2025.

However, within the Healthcare sector 93 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 555.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change -4.6 % -2.45 % -2.45 % -2.45 % -5.64 %
Y / Y Net Income Change -48.24 % - - - -8.41 %
Net Income (TTM) in million 94 181 181 181 181
Return On Assets (TTM) 12.18 % 23.24 % 23.1 % 22.96 % 22.82 %
INMD's Total Ranking # 555 # # # # 189
Total Assets (TTM) in million 781 767 767 767 819
Seq. Total Assets Change 1.83 % 0 % 0 % -6.31 % 4.13 %
Seq. Net Income Change - - - - -

INMD's 5 Years Annual ROA >> Back to INMD Management Effectiveness >> Compare INMD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 24
Sector # 94
Overall # 549

Return On Assets Statistics
High Average Low
34.5 %
23.86 %
12.24 %
(Dec 31 2021)   (Dec 31 2025)





Financial Statements
Inmode Ltd 's Assets $ 781 million INMD's Balance sheet
Inmode Ltd 's Income $ 94 million Quarterly INMD's Income Statement
INMD's Income by Division See INMD's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -4.6 % -5.64 % 28.86 % 30.76 % 65.01 %
Total Assets in million 781 819 868 673 515
Y / Y Net Income Change -48.24 % -8.41 % 22.54 % -2.15 % 120.03 %
Net Income in million 94 181 198 162 165
Annual Return On Assets 12.01 % 22.14 % 22.81 % 23.98 % 32.05 %

INMD's 5 Years Annual ROA >> Back to INMD Management Effectiveness >> Compare INMD ROA to its Competitors



Comment on INMD's ROA in the fiscal year ending 2025
In the fiscal year 2025 Inmode Ltd 's ROA decreased compared to previous year to 12.01 %, due to deterioration of net income -48.24 % to $93.83 million, from $181.28 million a year ago, as INMD's assets were $781.20 million.


More Return On Assets Ratios
INMD's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
INMD's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for INMD's Competitors
Subscribers only: Roa for Inmode Ltd 's Suppliers
Subscribers only: Return On Assets for INMD's Customers

You may also want to know
INMD's Roi INMD's Inventory Turnover Ratio INMD's Growth Rates INMD's Dividend Comparisons
INMD's Profitability Ratios INMD's Asset Turnover Ratio INMD's Dividend Growth
INMD's Roe INMD's Valuation Ratios INMD's Financial Strength Ratios INMD's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA
Idexx Laboratories Inc  31.91 %
Acadia Pharmaceuticals Inc   29.77 %
Newgenivf Group Limited  29.73 %
Hutchmed china Limited  26.11 %
Petros Pharmaceuticals inc   26.04 %
Adma Biologics Inc   25.98 %
Theravance Biopharma inc   25.35 %
Ptc Therapeutics inc   25.21 %
Qhslab Inc   25.12 %
Medpace Holdings Inc   25.07 %
Mettler toledo International Inc   25.07 %
Compugen Ltd  22.57 %
Lifemd Inc   21.39 %
Catalyst Pharmaceuticals Inc   21.24 %
Iradimed Corporation  20.83 %
Incyte Corporation  20.70 %
Transmedics Group Inc   20.34 %
Eli Lilly And Company  19.76 %
Innoviva Inc   19.19 %
Novo Nordisk A  18.87 %
Resmed Inc   18.44 %
Pro dex Inc   18.07 %
Zoetis Inc   17.92 %
Inspire Medical Systems inc   17.91 %
United Therapeutics Corporation  17.29 %
Krystal Biotech Inc   17.12 %
Electromed Inc   16.83 %
Arrowhead Pharmaceuticals Inc   16.32 %
Vertex Pharmaceuticals Inc  16.23 %
Chemed Corporation  16.06 %

Date modified: 2026-07-07T11:34:17+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.